MediGene and Will-Pharma Sign Agreement for the Commercialization of Veregen in Benelux
15-Mar-2011 -
MediGene AG has signed an exclusive license and supply agreement with Will-Pharma for the commercialization and marketing of Veregen® ointment in Belgium, the Netherlands and Luxembourg. Will-Pharma will market, promote and distribute the drug for the treatment of genital warts. Further ...
Belgium
Luxembourg
MediGene
+1